Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.
about
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenzaImmunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderlyPandemic Threat Posed by Avian Influenza A VirusesHuman illness from avian influenza H7N3, British ColumbiaRecipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virusLack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesA single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine developmentAvian Influenza Viruses, Inflammation, and CD8(+) T Cell ImmunityEmerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?Enhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferretA Systematic Review and Meta-Analysis of the Seroprevalence of Influenza A(H9N2) Infection Among HumansUltrasensitive electrochemical immunoassay for avian influenza subtype H5 using nanocompositeReplication-competent fluorescent-expressing influenza B virusNovel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virusAureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein HemagglutininDetection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus cultureEvidence for subclinical avian influenza virus infections among rural Thai villagersH5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelEvolution of H3N2 influenza virus in a guinea pig modelSafety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsSafety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studySeroprevalence of antibodies to avian influenza virus A (H5N1) among residents of villages with human cases, Thailand, 2005Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenzaSafety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant.Heterologous prime-boost vaccination using an AS03B-adjuvanted influenza A(H5N1) vaccine in infants and children<3 years of age.Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsRapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.Avian influenza A H5N1 virus: a continuous threat to humans.Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.The role of genomics in the identification, prediction, and prevention of biological threats.Immunity to influenza A H9N2 viruses induced by infection and vaccination.Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infectionPathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.Comparative serological assays for the study of h5 and h7 avian influenza viruses.Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.
P2860
Q21091074-885B5093-808B-47F9-8C53-924771A6ADEBQ21560857-4C8614ED-C23C-42DA-A39C-9AE6BA359E43Q22299330-247CDA3B-609E-4870-8ECC-5CBA287504CDQ24599066-CDB04EF5-9DEF-4C7D-9DA0-37E25AD43F90Q24600337-0577B479-AA99-4540-9FB0-FC63CFE5B7E0Q24646810-EB0EBF77-EDB2-44F1-A9D1-2F5009BA1FCDQ24649949-73C899DF-1F54-44AF-BE1F-9ED882BAD0DEQ24656615-DE68C9E9-BABC-4BC3-9B1E-A6D116880384Q26765927-9A66F94F-7C36-41BE-9DF1-08598D628CA2Q26783481-E5E4E31E-7FED-4B91-891C-6B5BAA2CDF60Q27336156-D04F423E-E6E7-4952-B4E2-033F76B08577Q28084860-60C5FB32-5F75-4E17-8570-2D2B0DDF816BQ28383980-3D9C7148-ADEB-4956-AF16-58E6ED2DFC4AQ28387786-0343D879-A0B4-4259-B595-D48E678D797BQ28396817-17BD195F-F622-4592-A220-CE2B6244DDF4Q28550191-00589EDE-1634-4EA0-941B-46BFDFEF6C0AQ28659731-665CDEB4-FF03-47E0-BF1D-BFDF3483F998Q28740370-81C4BD8E-AF6D-4FC0-8609-8CFE8918769BQ28741304-257DE0C4-DDF6-4A70-B247-38D4A779C245Q28742283-D55DD3BD-FE7F-4CAC-841A-27FB23B7087FQ28748654-2174FFCD-3641-4C08-978B-C5AE06D4227EQ28751886-6D601481-1A39-4BB5-B73A-50A83C5EE5B9Q28754258-FD342837-F03B-43EF-973B-626AFC1C826CQ28757651-14313EA3-251E-4A68-AB5E-8431A2F4AEF6Q30204578-7EF5C853-296B-4CA5-82A5-AD88D45EDECDQ30209583-39D1B65E-A190-435D-BA8C-326DB15EF484Q30210481-939B83BB-909D-4C2D-92C5-55600D1D429AQ30222441-A83776C2-C301-40C1-9674-CE4942AE8759Q30223536-824E4525-E0EA-408A-AC32-DA60A51DB6F1Q30224462-70FB3ED0-299C-4C1B-9239-6C5D95DE0B22Q30224646-2C3A86A8-BA1B-487C-8F15-864984250478Q30227467-F5D09EA6-F96E-4658-9E36-6E990EDB078BQ30233611-8D997186-A157-4CC7-8F25-E6618CF1FF72Q30328172-C25F3A66-02B1-45D9-92E5-F274CFB3CC64Q30339011-F65550E4-D1BE-419A-805D-C075ABC76D35Q30352927-47FCD241-2053-46EF-976F-41D2920BC85FQ30353786-9214D7AA-1342-42FD-AE47-7E50DE93B334Q30354952-08D826A8-8A18-4AE1-9982-8A05C6F06DCCQ30357455-D5B112F4-6932-4A3C-BF57-870221917E3BQ30359896-346D846B-A3A6-4B57-B0C0-548E27202195
P2860
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Detection of antibody to avian ...... mbination of serologic assays.
@ast
Detection of antibody to avian ...... mbination of serologic assays.
@en
type
label
Detection of antibody to avian ...... mbination of serologic assays.
@ast
Detection of antibody to avian ...... mbination of serologic assays.
@en
prefLabel
Detection of antibody to avian ...... mbination of serologic assays.
@ast
Detection of antibody to avian ...... mbination of serologic assays.
@en
P2093
P2860
P1476
Detection of antibody to avian ...... ombination of serologic assays
@en
P2093
J Hu-Primmer
R A Abernathy
W W Thompson
P2860
P304
P407
P577
1999-04-01T00:00:00Z